These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6442639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF, Alberca I, Tabernero MD, Cordero M, Del Pino-Montes J, Vicente V.
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for thrombosis in lupus patients.
    Hasselaar P, Derksen RH, Blokzijl L, Hessing M, Nieuwenhuis HK, Bouma BN, De Groot PG.
    Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863
    [Abstract] [Full Text] [Related]

  • 9. Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Averbuch M, Koifman B, Levo Y.
    Am J Med Sci; 1987 Jan; 293(1):2-5. PubMed ID: 3101499
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J, Vilardell Tarrés M, Barquinero Máñez J, Selva O'Callaghan A, Alijotas Reig J, Bosch Gil J.
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The lupus inhibitor].
    Carreras LO, Vermylen J.
    Sangre (Barc); 1981 Feb; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract] [Full Text] [Related]

  • 14. Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.
    Jarrett MP, Green D, Ts'ao CH.
    J Clin Pathol; 1983 Mar; 36(3):357-60. PubMed ID: 6826782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M.
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [Abstract] [Full Text] [Related]

  • 19. Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant.
    Lo SC, Salem HH, Howard MA, Oldmeadow MJ, Firkin BG.
    Br J Haematol; 1990 Nov; 76(3):380-6. PubMed ID: 2175638
    [Abstract] [Full Text] [Related]

  • 20. Lupus anticoagulant and thrombosis in systemic lupus erythematosus.
    Jungers P, Liote F, Dautzenberg MD, Gazengel C, Dougados M, Tron F, Bach JF.
    Lancet; 1984 Mar 10; 1(8376):574-5. PubMed ID: 6142298
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.